NCT06991205

Brief Summary

The investigator aims to conduct a feasibility randomized controlled trial (RCT) (N=50) to test the feasibility, acceptability, and credibility of an asynchronous web-based mind-body intervention (Toolkit for Resilient Life beyond Pain and Substance Use; Web-TIRELESS) versus web-based minimally enhanced usual care (Web-MEUC) among adult patients with a painful non-traumatic upper-extremity condition(s) (PNUC) and commorbid risky substance use. Deliverables: \[1\] Adapt and refine open pilot protocol, patient recruitment, and other study materials. \[2\] Assess the feasibility, acceptability, and credibility of Web-TIRELESS and Web-MEUC in preparation for future research.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
10mo left

Started Sep 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Sep 2025Mar 2027

First Submitted

Initial submission to the registry

May 19, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 27, 2025

Completed
4 months until next milestone

Study Start

First participant enrolled

September 15, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

March 13, 2026

Status Verified

March 1, 2026

Enrollment Period

1.5 years

First QC Date

May 19, 2025

Last Update Submit

March 11, 2026

Conditions

Keywords

Upper Extremity ProblemRisky substance useRandomized Controlled Trial (RCT)MindfulnessNontraumatic conditionsChronic painPsychiatryFeasibility

Outcome Measures

Primary Outcomes (8)

  • Credibility and Expectancy Questionnaire (CEQ)

    Assesses the degree to which one believes the intervention will effectively manage their condition, substance use, and related worry. Possible scores range from 3 to 27 for both the credibility and the expectancy subscales. Higher scores represent higher credibility and expectancy.

    Baseline (0 Weeks)

  • Client Satisfaction Questionnaire to assess satisfaction with/acceptability of treatment

    Participants' satisfaction with treatment received after completion. The score range is 0-12. Higher scores indicate greater satisfaction.

    Post-Test (5 Weeks)

  • The User Experience Scale to assess participants' satisfaction with (acceptability of) web-based delivery

    This measure will assess how well patients like the Wed-based program content and delivery. Total raw scores range from 22 to 110 with higher scores indicating greater satisfaction with the platform.

    Post-Test (5 Weeks)

  • The percent of patients that agree to participate to assess feasibility of recruitment

    The percent of eligible patients approached that agree to participate.

    Baseline (0 Weeks)

  • Rate at which program was accepted, measured by attendance to assess acceptability of treatment

    The proportion of Web-TIRELESS participants who complete \> or = 3 of 4 sessions.

    Post-Test (5 Weeks)

  • Adherence to homework

    Rate of Web-TIRELESS participant's completion of homework assigned throughout the study.

    Throughout intervention completion, an average of 1 month

  • Rate of participant's completion of self-report measures to assess feasibility of assessments

    Investigators will report number of patients who complete assessments at each time-point.

    Baseline (0 Weeks), Post-Test (5 Weeks)

  • Adverse Events

    Any self-reported or observed negative events related to participation.

    Throughout intervention completion, an average of 1 month

Secondary Outcomes (11)

  • Graded Chronic Pain Scale (GCPS)

    Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months)

  • Disabilities of the Arm, Shoulder and Hand (DASH)

    Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months)

  • Patient Reported Outcomes Measurement Information System (PROMIS) Emotional Distress - Depression-Short Form 8a v1.0

    Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months)

  • PROMIS Emotional Distress - Anxiety-Short Form 8a v1.0

    Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months)

  • Pain Catastrophizing Scale (PCS)

    Baseline (0 Weeks), Post-Test (5 Weeks), Follow-Up (6 Months)

  • +6 more secondary outcomes

Study Arms (2)

Web-TIRELESS

EXPERIMENTAL

A 4-session, asynchronous, web-based mind-body pain and substance use management intervention.

Behavioral: Web-TIRELESS

Web-MEUC

ACTIVE COMPARATOR

Open access to a web-based pamphlet containing brief, educational information and coping techniques.

Other: Web-MEUC

Interventions

An educational information web-based pamphlet, containing brief, summarized information tailored for the respective patient population that follows topics including the trajectory of pain and adaptation after non-traumatic painful upper extremity conditions, the role of relaxation strategies to manage pain, and the importance of returning to engagement in activities of daily living.

Web-MEUC
Web-TIRELESSBEHAVIORAL

This is a self-administered web-based intervention that consists of 4 on-demand sessions, each \~30 minutes long, that teach mind-body skills, cognitive-behavioral strategies (e.g., reframing, pain and substance use urge surfing), activity pacing, acceptance and commitment skills, and psychoeducation on the association between substance use and pain. The program aims to increase patients' physical and emotional functioning and decrease pain intensity and maladaptive substance use behaviors.

Web-TIRELESS

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Outpatient adults seeking care in the Hand and Arm Center
  • Diagnosed with a non-traumatic painful upper-extremity condition (NPUC)
  • Pain score \> 4 on the Numerical Rating Scale (NRS)
  • Risky substance use (scores \>10 and \<27 for alcohol, and \>3 and \<27 for cannabis, cocaine, amphetamine-type stimulants, inhalants, sedatives, hallucinogens, opioids, tobacco products, and e-cigarette on The World Health Organization's - Alcohol, Smoking and Substance Involvement Screening Test \[WHO-ASSIST\])
  • Owns a smartphone, laptop, or computer with internet access
  • Age ≥18yr
  • English fluency
  • Ability and willingness to participate in a live video focus group and the following asynchronous Web-based intervention

You may not qualify if:

  • Participation in mind-body or specialized substance abuse treatment in the past 3 months
  • Practice of mindfulness \>45 minutes/week in the past 3 months
  • Psychotropic medications (e.g. antidepressants) changed in the past 3 months
  • Serious untreated mental illness (e.g., Schizophrenia)
  • Suicidal ideation with intent or plan
  • Pregnancy
  • Secondary gains that may bias motivation (e.g., pending disability claim),
  • Moderate to severe cognitive impairment (score ≥4 on the Short Portable Mental Status Questionnaire (SPMSQ))
  • History of surgery for the presented NPUC within the past 6 months OR future plans for surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

RECRUITING

MeSH Terms

Conditions

Musculoskeletal DiseasesChronic Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Jafar Bakhshaie, MD, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jafar Bakhshaie, MD, PhD

CONTACT

Kozbi B Cliff, BS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 19, 2025

First Posted

May 27, 2025

Study Start

September 15, 2025

Primary Completion (Estimated)

March 1, 2027

Study Completion (Estimated)

March 1, 2027

Last Updated

March 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations